HeartBeam Partners with HeartNexus to Expand Remote Cardiac Diagnostic Access

HeartBeam Inc. (NASDAQ: BEAT) has announced a strategic collaboration with HeartNexus to expand access to cardiologist-level electrocardiogram insights for arrhythmia assessment. The partnership addresses the critical need for improved cardiac diagnostics as cardiovascular disease remains the leading cause of mortality worldwide, responsible for an estimated 17.9 million deaths annually according to the World Health Organization.

The collaboration combines HeartBeam's portable ECG technology with HeartNexus's telemedicine platform, making board-certified cardiologists available 24/7 to interpret ECG results. This integration allows patients to receive expert feedback directly or through coordinating clinicians, potentially reducing the time between symptom onset and professional assessment. The HeartBeam System enables patients to capture 30-second ECG recordings using a credit-card-sized, cable-free device that can be used anywhere, eliminating the need for immediate clinical visits for standard ECG testing.

Cardiovascular disease statistics underscore the importance of this technological advancement. The World Health Organization data highlights the global burden of heart-related conditions, emphasizing the need for more accessible diagnostic tools. Traditional ECG testing often requires specialized equipment and clinical visits, creating barriers to timely diagnosis and treatment. The HeartBeam-HeartNexus partnership aims to overcome these limitations by providing professional cardiac assessment capabilities outside traditional healthcare settings.

The HeartBeam System functions as a portable non-invasive recorder designed to capture, store, and transfer three-lead electrocardiogram data from five electrodes. The device is cleared for use by adult patients in both clinical and home environments. While the device itself does not conduct cardiac analysis, it works with ECG Viewer software systems for manual interpretation of non-life-threatening arrhythmias by healthcare professionals. Full safety information is available through the company's official documentation.

This collaboration represents a significant step in telemedicine and remote patient monitoring, particularly for cardiac care. The ability to obtain professional ECG interpretation remotely could benefit patients in rural areas, those with mobility limitations, and individuals who experience intermittent cardiac symptoms that might not be captured during scheduled clinical appointments. The partnership's 24/7 availability model addresses the unpredictable nature of cardiac events, potentially leading to earlier detection and intervention for arrhythmias and other cardiac conditions.

Investors can access the latest news and updates relating to BEAT through the company's newsroom at https://ibn.fm/BEAT. The strategic collaboration between HeartBeam and HeartNexus demonstrates the growing intersection of medical technology and telemedicine services, offering new possibilities for managing cardiovascular health through remote monitoring and expert consultation.